PARKINSON'S DISEASE NEWS
26th August 2013 - New research
NAVAJO HAVE ONE OF THE HIGHEST PREVALENCES OF PARKINSON'S DISEASE
Journal of Parkinson's Disease 
3 (2) : 193-198 (P.H.Gordon, H.Zhao, D.Bartley, L.J.Sims, M.G.Begay, S.
Pirio Richardson, J.Lewis, A.S.Rowland)
These figures are higher than for any U.S. state with Nebraska having the highest prevalence at 329 per 100,000. Amongst Navajo men it is even higher at 438 per 100,000. The Navajo are concentrated in Arizona and New Mexico in the USA. For more information go too Navajo. Native Americans, including American Indian and Alaska Native peoples as a whole have an even higher prevalence rate of 355 per 100,000. It is not known why the prevalence is so high amongst Native Americans. For more information concerning prevalence go to Prevalence of Parkinson's Disease. For a printable version of this article click here. In order to refer to this article on its own click here.
24th August 2013 - News report
LINDA RONSTADT DIAGNOSED WITH PARKINSON'S DISEASE
American singer Linda Ronstadt has been diagnosed with Parkinson's Disease and
consequently can no longer sing. She won 11 Grammy Awards and has gold, platinum
and multiplatinum albums. sing. For more information go to
Linda Ronstadt. Linda Ronstadt, who is
now 67, told AARP today that she was daignosed with Parkinson's Disease 8 months
ago and that she began to show symptoms 8 years ago. Linda Ronstadt now walks
with the aid of poles when on uneven ground and uses a wheelchair when she
travels. However, her soon to be published autobiography makes no mention of her
having Parkinson's Disease. For more information
23rd August 2013 - New book
YOGA AND PARKINSON'S DISEASE
Peggy Van Hulsteyn
Publisher's description : Yoga and Parkinson's Disease is a practical guide to using yoga to manage stress, improve mental alertness, increase flexibility, correct posture and improve the quality-of-life of readers with Parkinson's. It follows the author's own experience and research studies in the subject that have shown a correlation between yoga practice and better health and outcomes after a Parkinson's Disease diagnosis. The book is a deeply soothing form of moving meditation and physical activity that is a safe way to rebuild strength, stamina, and flexibility. It shows how yoga ameliorates difficulties that accompany Parkinson's, including mobility, range of motion, and balance. Click here for more details. For more books concerning Parkinson's Disease go to Parkinson's Disease Books.
18th August 2013 - New research
THE EFFECT OF GAMMA KNIFE THALAMOTOMY ON TREMOR
Journal of Neurosurgery  118 (4) : 713-718 (A.Kooshkabadi, L.D.Lunsford,
D.Tonetti, J.C.Flickinger, D.Kondziolka)
Knife radiosurgical thalamotomy is a technique in which a thalamotomy is
performed with beams of radiation rather than a surgical incision or use of
electrodes. The surgeon uses a Gamma Knife device to focus high-energy gamma
rays precisely on an area in the brain that causes tremor. These rays result
in the death of the brain cells that generate tremor. The procedure takes
approximately one hour and the benefit may not be apparent until three to
six weeks afterwards. For more information go
Gamma knife surgery.
13th August 2013 - New research
BIOMARKERS FAIL TO DIAGNOSE PARKINSON'S DISEASE
BMC Neurology  Apr 12
[Epub ahead of print] (D.J.McGhee, P.L.Royle, P.A.Thompson,
D.E.Wright, J.P.Zajicek, C.E.Counsell)
A systematic review was undertaken to determine which biomarkers for disease progression in Parkinson's Disease exist. 183 studies were included. The sensitivity of the tests was an average of 71%, which is insufficient for Parkinson's Disease diagnosis. However, the range in sensitivity was between 51% and 86% showing that some of the methods were closer to having a practical use but were still less accurate than other methods of diagnosing Parkinson's Disease that are available. The authors found insufficient evidence to recommend the use of any biomarker for assessing disease progression in Parkinson's Disease clinical trials. They believe that this may simply reflect the poor quality of research in this area. They therefore present a provisional 'roadmap' for conducting future disease progression biomarker studies and recommend new quality criteria by which future studies may be judged. For a printable version of this article click here. In order to refer to this article on its own click here.
8th August 2013 - New research
DIABETIC DRUG TO TREAT PARKINSON'S DISEASE
Journal of Clinical Investigation  123 (6) : 2730-2736 (I.Aviles-Olmos,
J.Dickson, Z.Kefalopoulou, A. Djamshidian, P.Ell, T.Soderlund, P.Whitton,
R.Wyse, T.Isaacs, A.Lees, P.Limousin, T.Foltynie)
People with moderate Parkinson's Disease received subcutaneous injections of Exenatide for a year. Their Parkinson's Disease was compared after overnight withdrawal of conventional Parkinson's Disease medication using the Unified Parkinson's Disease Rating Scale (UPDRS). Exenatide was well tolerated but weight loss was common. There were clinically relevant improvements in Parkinson's Disease motor and cognitive measures. Exenatide treated patients had a mean improvement after one year on the UPDRS of 2.7 compared with a mean decline of 2.2 points in controls.. The authors do not make suggestions as to how the diabetes drug has effect in Parkinson's Disease. For a printable version of this article click here. In order to refer to this article on its own click here.
7th August 2013 - News release
BASEBALL STAR DIAGNOSED WITH PARKINSON'S DISEASE
Dave Parker, a two time winner of the baseball World Series has been diagnosed with Parkinson's Disease. Dave Parker is a retired American baseball player. He began his career in the Major League in 1973 with the Pittsburgh Pirates, where he spent ten years. He went on to play with Cincinnati Reds, Oakland Athletics, Milwaukee Brewers, California Angels, and Toronto Blue Jays. He won the World Series twice, in 1979 and 1989. He retired from baseball in 1991. Now aged 62, he was first diagnosed with Parkinson's Disease early in 2012 but kept it quiet until now except for informing some close friends. For the time being he is not taking any medication and is instead relying on natural remedies. For more information concerning him go to Dave Parker
4th August 2013 - New research
CLINICAL TRIAL OF AFQ056 FOR DYSKINESIA
Movement Disorders  July 11 [Epub ahead of print] (Stocchi F, Rascol O,
Destee A, Hattori N, Hauser RA, Lang AE, Poewe W, Stacy M, Tolosa E, Gao H,
Nagel J, Merschhemke M, Graf A, Kenney C, Trenkwalder C.)
Patients taking 200mg AFQ056 daily demonstrated significant improvements on the modified Abnormal Involuntary Movements Scale. There was a dose-response relationship, with 200 mg daily demonstrating the greatest effect. However, no significant changes were observed on the 26-item Parkinson's Disease Dyskinesia Scale or the Patient's / Clinician's Global Impression of Change. Unified Parkinson's Disease Rating Scale part III scores were not significantly changed, indicating no worsening of motor symptoms. The most common adverse events were dizziness, hallucination, fatigue, nasopharyngitis, diarrhea, and insomnia. These results can guide the slection of doses for future clinical trials.. For a printable version of this article click here. In order to refer to this article on its own click here.